Comparison between FCML Distributors IPO and Invicta Diagnostic IPO.
FCML Distributors IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Invicta Diagnostic IPO is a SME Bookbuilding proposed to list at NSE SME.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. | Socradamus Capital Pvt.Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of FCML Distributors IPO is up to ₹0.00 Cr whereas the issue size of the Invicta Diagnostic IPO is up to ₹0.00 Cr. The final issue price of FCML Distributors IPO is and of Invicta Diagnostic IPO is .
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 45,96,000 shares | 33,08,800 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 11,46,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,42,000 shares | 33,08,800 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
FCML Distributors IPO opens on , while Invicta Diagnostic IPO opens on . The closing date of FCML Distributors IPO and Invicta Diagnostic IPO is , and , respectively.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
FCML Distributors IPO P/E ratio is , as compared to Invicta Diagnostic IPO P/E ratio of .
| FCML Distributors IPO | Invicta Diagnostic IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | FCML Distributors Limited Financial Information (Restated Consolidated)FCML Distributors Limited's revenue increased by 14% and profit after tax (PAT) rose by 17% between the financial year ending with March 31, 2025 and March 31, 2024.
| Invicta Diagnostic Limited Financial Information (Restated Consolidated)Invicta Diagnostic Limited's revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 91.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.29% | 44.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.93% | 42.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 29.27% | 36.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the FCML Distributors IPO Retail Individual Investors (RII) are offered 0 shares while in Invicta Diagnostic IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in FCML Distributors IPO and 0 shares in Invicta Diagnostic IPO.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 0 shares |
| Market Maker Reserveration | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
FCML Distributors IPO subscribed in total, whereas Invicta Diagnostic IPO subscribed .
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
